Roche boosts 2019 sales outlook, sees Spark deal this year
Share:
ZURICH (Reuters) - Swiss drugmaker Roche boosted its 2019 sales outlook for a third time, helped by rising Chinese revenue, and said it expects to finish its $4.3 billion takeover of Spark Therapeutics this year despite repeated delays.Sales are now expected to grow at a high-single-digit rate, at constant exchange rates, up from the mid- to high-single digit range projected in July, it said on Wednesday. Sales in the third quarter rose 13% to 15.6 billion Swiss francs ($15.64 billion), the..